Overexpression of antiapoptotic proteins such as BCL2, BCL2L1/BCL-XL, and MCL1, on the other hand, negatively correlates with response to cisplatin in ovarian or head and neck squamous cell carcinoma (HNSCC) patients (Supplementary Table S1). This evidence concerns the gene BCL2L1 and head and neck squamous cell carcinoma.